Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva licenses Mersana cancer treatment for $334M
Teva licenses Mersana cancer treatment for $334M
Teva licenses Mersana cancer treatment for $334M
Submitted by
admin
on April 14, 2010 - 9:13am
Source:
Yahoo/AP
News Tags:
Teva Pharmaceuticals
Mersana
cancer
liscensing
Headline:
Teva licenses Mersana cancer treatment for $334M
Do Not Allow Advertisers to Use My Personal information
